HC Wainwright & Co. Maintains Buy on Korro Bio, Lowers Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Korro Bio (NASDAQ:KRRO) but lowered the price target from $115 to $100.
May 15, 2024 | 3:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has maintained a Buy rating on Korro Bio but lowered the price target from $115 to $100.
The Buy rating suggests continued confidence in Korro Bio's prospects, but the lowered price target indicates some tempered expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100